FDANonrulemakingFDA-2020-D-1137
Who commented on this docket
Center for Biologics Evaluation and Research (CBER): COVID-19
1 organizations filed 1 public comment on Center for Biologics Evaluation and Research (CBER): COVID-19, at the Food and Drug Administration. The comment window closed 1174d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 1174d ago
Commenters (1)
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.